Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$139.53 /

-2.29 (-1.61%)

12:33
05/22/20
05/22
12:33
05/22/20
12:33

Alnylam presents long-term results from Global OLE study of ONPATTRO

Alnylam Pharmaceuticals presented new results from the Global Open-Label Extension study of ONPATTRO, an RNAi therapeutic for the treatment of the polyneuropathy of hereditary ATTR amyloidosis in adults, at the European Academy of Neurology Virtual Congress. In addition, interim results were presented from a Phase 3b trial evaluating treatment with patisiran in patients with hATTR amyloidosis with disease progression after receiving an orthotopic liver transplant. 24-month interim results were presented from the ongoing Global OLE study of patisiran evaluating the drug's long-term efficacy and safety in eligible patients who completed the Phase 2 OLE and APOLLO Phase 3 studies. The data shared include 178 patients who had 24 months or greater of exposure as of an October 7, 2019 cutoff date. Reductions in serum TTR levels were maintained in patisiran-treated patients with continued dosing in the Global OLE study. Patients on treatment for 42 months demonstrated sustained improvement in neuropathy impairment and quality of life relative to APOLLO study baseline, as shown by mean negative changes in modified Neuropathy Impairment Score + 7 and Norfolk Quality of Life - Diabetic Neuropathy scores. Patients on treatment from the Phase 2 OLE population also demonstrated an improvement in mNIS+7 score over 48 months. For APOLLO placebo patients subsequently treated with patisiran for 24 months in the OLE study, neuropathy progression was also notably halted and QOL improved. However, these patients had experienced rapid progression while on placebo in the APOLLO study and did not return to their baseline scores, highlighting the importance of patients starting treatment with patisiran early. The long-term safety profile of patisiran was consistent with that observed and previously reported in the APOLLO Phase 3 study and the Phase 2 OLE study. In addition, data were presented from an interim analysis of the Phase 3b open-label study conducted across several European countries to evaluate the safety, efficacy and pharmacokinetics of patisiran in patients with hATTR amyloidosis with disease progression after receiving an orthotopic liver transplant. Historically, OLT has been used to slow disease progression in patients with early stages of hATTR amyloidosis; however, some patients experience disease progression after the transplant due to continued amyloid deposition of wild-type TTR on top of existing amyloid deposits in tissues. Twenty-three patients who showed disease progression post-OLT received patisiran infusion every three weeks. After 3 weeks of patisiran treatment, the mean reduction from baseline in serum TTR levels was 81.9 percent. At the time of interim safety analysis, the safety profile of patisiran in this Phase 3b study was consistent with that observed and previously reported in the APOLLO Phase 3 study. The safety, efficacy, and PK of patisiran treatment post-OLT will be further investigated in this ongoing study.

ALNY Alnylam
$139.53 /

-2.29 (-1.61%)

05/12/20 RBC Capital
Alnylam initiated with a Sector Perform at RBC Capital
05/07/20 Oppenheimer
Alnylam price target raised to $162 from $140 at Oppenheimer
05/07/20 Cantor Fitzgerald
Alnylam's fundamental launch trends look 'good,' says Cantor Fitzgerald
05/07/20 Barclays
Alnylam price target raised to $156 from $143 at Barclays

TODAY'S FREE FLY STORIES

Syndicate
Trinity Biotech files $200M mixed securities shelf  16:10
07/06/20
07/06
16:10
07/06/20
16:10
TRIB

Trinity Biotech

$2.54 /

+0.225 (+9.74%)

 
ShowHide Related Items >><<
TRIB Trinity Biotech
$2.54 /

+0.225 (+9.74%)

TRIB Trinity Biotech
$2.54 /

+0.225 (+9.74%)

Hot Stocks
Chubb announces Q2 global net catastrophic loss estimates of $1.81B » 16:09
07/06/20
07/06
16:09
07/06/20
16:09
CB

Chubb

$127.24 /

+1.69 (+1.35%)

Chubb Limited announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CB Chubb
$127.24 /

+1.69 (+1.35%)

CB Chubb
$127.24 /

+1.69 (+1.35%)

06/23/20 Piper Sandler
Chubb price target raised to $145 from $131 at Piper Sandler
04/24/20 Raymond James
Raymond James downgrades Travelers to Underperform on COVID-19 impact
04/23/20 Wells Fargo
Chubb price target lowered to $142 from $150 at Wells Fargo
04/22/20 MKM Partners
Chubb price target lowered to $145 from $170 at MKM Partners
CB Chubb
$127.24 /

+1.69 (+1.35%)

CB Chubb
$127.24 /

+1.69 (+1.35%)

Initiation
PayPal initiated with an Overweight at Piper Sandler » 16:09
07/06/20
07/06
16:09
07/06/20
16:09
PYPL

PayPal

$175.77 /

-1.45 (-0.82%)

Piper Sandler initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$175.77 /

-1.45 (-0.82%)

PYPL PayPal
$175.77 /

-1.45 (-0.82%)

16:08 Today Piper Sandler
Correction: PayPal initiated with an Overweight at Piper Sandler
07/02/20 Wedbush
PayPal price target raised to $200 from $176 at Wedbush
06/30/20
Fly Intel: Top five analyst initiations
06/30/20 Canaccord
PayPal price target raised to $190 from $160 at Canaccord
PYPL PayPal
$175.77 /

-1.45 (-0.82%)

PYPL PayPal
$175.77 /

-1.45 (-0.82%)

PYPL PayPal
$175.77 /

-1.45 (-0.82%)

PYPL PayPal
$175.77 /

-1.45 (-0.82%)

Hot Stocks
Great Lakes Dredge receives $51.1M in dredging awards » 16:09
07/06/20
07/06
16:09
07/06/20
16:09
GLDD

Great Lakes Dredge

$8.85 /

+0.035 (+0.40%)

Great Lakes Dredge…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLDD Great Lakes Dredge
$8.85 /

+0.035 (+0.40%)

GLDD Great Lakes Dredge
$8.85 /

+0.035 (+0.40%)

Initiation
Square initiated with a Neutral at Piper Sandler » 16:09
07/06/20
07/06
16:09
07/06/20
16:09
SQ

Square

$118.48 /

+5.18 (+4.57%)

Piper Sandler initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$118.48 /

+5.18 (+4.57%)

SQ Square
$118.48 /

+5.18 (+4.57%)

07:16 Today SunTrust
Square price target raised to $150 from $83 at SunTrust
07/01/20 MoffettNathanson
Square price target raised to $120 from $90 at MoffettNathanson
07/01/20 Rosenblatt
Square upgraded to Buy from Neutral at Rosenblatt
07/01/20 Rosenblatt
Square upgraded to Buy from Neutral at Rosenblatt
SQ Square
$118.48 /

+5.18 (+4.57%)

SQ Square
$118.48 /

+5.18 (+4.57%)

SQ Square
$118.48 /

+5.18 (+4.57%)

SQ Square
$118.48 /

+5.18 (+4.57%)

Hot Stocks
Marrone Bio appoints Kevin Helash as CEO » 16:07
07/06/20
07/06
16:07
07/06/20
16:07
MBII

Marrone Bio

$1.07 /

-0.025 (-2.28%)

Marrone Bio Innovations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBII Marrone Bio
$1.07 /

-0.025 (-2.28%)

MBII Marrone Bio
$1.07 /

-0.025 (-2.28%)

07/24/19 Aegis
Marrone Bio initiated with a Buy at Aegis
MBII Marrone Bio
$1.07 /

-0.025 (-2.28%)

MBII Marrone Bio
$1.07 /

-0.025 (-2.28%)

Conference/Events
Smartsheet participates in a conference call with Stephens » 16:07
07/06/20
07/06
16:07
07/06/20
16:07
SMAR

Smartsheet

$51.06 /

-1.64 (-3.11%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMAR Smartsheet
$51.06 /

-1.64 (-3.11%)

SMAR Smartsheet
$51.06 /

-1.64 (-3.11%)

06/23/20
Fly Intel: Top five analyst initiations
06/23/20 Wells Fargo
Smartsheet initiated with an Equal Weight at Wells Fargo
06/04/20 DA Davidson
Smartsheet price target raised to $45 from $37 at DA Davidson
06/04/20 Stephens
Stephens would be buyer of Smartsheet amid pullback
SMAR Smartsheet
$51.06 /

-1.64 (-3.11%)

SMAR Smartsheet
$51.06 /

-1.64 (-3.11%)

SMAR Smartsheet
$51.06 /

-1.64 (-3.11%)

Hot Stocks
Parsons awarded $178M, five-year contract » 16:06
07/06/20
07/06
16:06
07/06/20
16:06
PSN

Parsons

$34.68 /

-0.25 (-0.72%)

Parsons Corporation was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$34.68 /

-0.25 (-0.72%)

PSN Parsons
$34.68 /

-0.25 (-0.72%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
PSN Parsons
$34.68 /

-0.25 (-0.72%)

PSN Parsons
$34.68 /

-0.25 (-0.72%)

Earnings
Pacira reports preliminary Q2 revenue $75.5M, consensus $57.81M » 16:05
07/06/20
07/06
16:05
07/06/20
16:05
PCRX

Pacira

$54.24 /

+2.04 (+3.91%)

Pacira BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
$54.24 /

+2.04 (+3.91%)

PCRX Pacira
$54.24 /

+2.04 (+3.91%)

07:47 Today Needham
Pacira price target raised to $64 from $52 at Needham
06:02 Today Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
PCRX Pacira
$54.24 /

+2.04 (+3.91%)

PCRX Pacira
$54.24 /

+2.04 (+3.91%)

Hot Stocks
Otonomy provides update on Otividex program » 16:05
07/06/20
07/06
16:05
07/06/20
16:05
OTIC

Otonomy

$3.12 /

-0.045 (-1.42%)

Otonomy provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTIC Otonomy
$3.12 /

-0.045 (-1.42%)

OTIC Otonomy
$3.12 /

-0.045 (-1.42%)

06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
06/01/20 Oppenheimer
Otonomy assumed with an Outperform at Oppenheimer
05/07/20 Piper Sandler
Piper still believes in potential success of three key Otonomy programs
02/07/20 Piper Sandler
Otonomy should be bought ahead of near-term readouts, says Piper Sandler
OTIC Otonomy
$3.12 /

-0.045 (-1.42%)

Syndicate
Revolution Medicines files to sell 5.5M shares of common stock » 16:03
07/06/20
07/06
16:03
07/06/20
16:03
RVMD

Revolution Medicines

$29.25 /

-1.75 (-5.65%)

J.P. Morgan, Cowen, SVB…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RVMD Revolution Medicines
$29.25 /

-1.75 (-5.65%)

RVMD Revolution Medicines
$29.25 /

-1.75 (-5.65%)

05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Cowen
Revolution Medicines initiated with an Outperform at Cowen
  • 13
    Feb
RVMD Revolution Medicines
$29.25 /

-1.75 (-5.65%)

Hot Stocks
United Insurance names Bradford Martz as President » 16:03
07/06/20
07/06
16:03
07/06/20
16:03
UIHC

United Insurance

$7.51 /

+ (+0.00%)

United Insurance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UIHC United Insurance
$7.51 /

+ (+0.00%)

UIHC United Insurance
$7.51 /

+ (+0.00%)

01/06/20 Wells Fargo
United Insurance downgraded to Underweight at Wells Fargo
01/06/20 Wells Fargo
United Insurance downgraded to Underweight from Equal Weight at Wells Fargo
UIHC United Insurance
$7.51 /

+ (+0.00%)

Hot Stocks
Central Valley Community names Patrick Luis chief credit officer » 16:02
07/06/20
07/06
16:02
07/06/20
16:02
CVCY

Central Valley Community

$14.79 /

-0.19 (-1.27%)

James M. Ford, President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVCY Central Valley Community
$14.79 /

-0.19 (-1.27%)

04/16/20
DA Davidson upgrades Central Valley Community to Buy on resilient NIM
04/16/20 DA Davidson
Central Valley Community upgraded to Buy from Neutral at DA Davidson
01/07/20 Raymond James
Central Valley Community downgraded to Market Perform at Raymond James
01/07/20 Raymond James
Central Valley Community downgraded to Market Perform from Outperform at Raymond James
CVCY Central Valley Community
$14.79 /

-0.19 (-1.27%)

Syndicate
Pacira to offer $300M of senior convertible notes due 2025  16:02
07/06/20
07/06
16:02
07/06/20
16:02
PCRX

Pacira

$54.26 /

+2.06 (+3.95%)

 
ShowHide Related Items >><<
PCRX Pacira
$54.26 /

+2.06 (+3.95%)

PCRX Pacira
$54.26 /

+2.06 (+3.95%)

07:47 Today Needham
Pacira price target raised to $64 from $52 at Needham
06:02 Today Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
PCRX Pacira
$54.26 /

+2.06 (+3.95%)

PCRX Pacira
$54.26 /

+2.06 (+3.95%)

Periodicals
Walmart, Target take down Washington NFL merchandise, Washington Post says » 16:00
07/06/20
07/06
16:00
07/06/20
16:00
WMT

Walmart

$118.67 /

-0.55 (-0.46%)

, TGT

Target

$118.85 /

-0.265 (-0.22%)

Walmart (WMT) said it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$118.67 /

-0.55 (-0.46%)

TGT Target
$118.85 /

-0.265 (-0.22%)

WMT Walmart
$118.67 /

-0.55 (-0.46%)

06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
06/22/20 Guggenheim
Walmart price target raised to $145 from $140 at Guggenheim
06/22/20 UBS
Walmart upgraded to Buy from Neutral at UBS
06/03/20 BTIG
Green Dot price target raised to $48 from $40 at BTIG
TGT Target
$118.85 /

-0.265 (-0.22%)

06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
06/19/20 Cleveland Research
Target upgraded to Buy from Neutral at Cleveland Research
05/21/20 Deutsche Bank
Target price target raised to $131 from $121 at Deutsche Bank
05/21/20 Nomura Instinet
Target price target raised to $135 from $121 at Nomura Instinet
WMT Walmart
$118.67 /

-0.55 (-0.46%)

TGT Target
$118.85 /

-0.265 (-0.22%)

WMT Walmart
$118.67 /

-0.55 (-0.46%)

TGT Target
$118.85 /

-0.265 (-0.22%)

WMT Walmart
$118.67 /

-0.55 (-0.46%)

TGT Target
$118.85 /

-0.265 (-0.22%)

WMT Walmart
$118.67 /

-0.55 (-0.46%)

TGT Target
$118.85 /

-0.265 (-0.22%)

Recommendations
Wells says merits of Dominion's 'forward-looking' deal to be clearer with time » 15:53
07/06/20
07/06
15:53
07/06/20
15:53
D

Dominion

$73.97 /

-8.715 (-10.54%)

Wells Fargo analyst Sarah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
D Dominion
$73.97 /

-8.715 (-10.54%)

D Dominion
$73.97 /

-8.715 (-10.54%)

14:23 Today Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
08:43 Today JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
08:39 Today JPMorgan
Dominion now positioned as 'best-in-class' utility, says JPMorgan
07:00 Today Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
D Dominion
$73.97 /

-8.715 (-10.54%)

D Dominion
$73.97 /

-8.715 (-10.54%)

D Dominion
$73.97 /

-8.715 (-10.54%)

D Dominion
$73.97 /

-8.715 (-10.54%)

Options
Trip.com call volume above normal and directionally bullish » 15:45
07/06/20
07/06
15:45
07/06/20
15:45
TCOM

Trip.com Group

$28.03 /

+1.47 (+5.53%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCOM Trip.com Group
$28.03 /

+1.47 (+5.53%)

TCOM Trip.com Group
$28.03 /

+1.47 (+5.53%)

06/10/20 BTIG
Trip.com Group initiated with a Neutral at BTIG
06/02/20 Barclays
Trip.com Group price target raised to $32 from $30 at Barclays
05/29/20 Nomura Instinet
Trip.com Group upgraded to Buy from Neutral at Nomura Instinet
05/29/20 Nomura Instinet
Trip.com Group upgraded to Buy from Neutral at Nomura Instinet
TCOM Trip.com Group
$28.03 /

+1.47 (+5.53%)

TCOM Trip.com Group
$28.03 /

+1.47 (+5.53%)

Periodicals
Facebook's Instagram tests TikTok rival Reels in India, Business Insider says » 15:40
07/06/20
07/06
15:40
07/06/20
15:40
FB

Facebook

$239.06 /

+5.6 (+2.40%)

A few day after the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$239.06 /

+5.6 (+2.40%)

FB Facebook
$239.06 /

+5.6 (+2.40%)

07/01/20 Monness Crespi
Facebook has opportunity to emerge from crisis stronger, says Monness Crespi
07/01/20 Goldman Sachs
Facebook checks show limited impact from ad boycott, says Goldman Sachs
06/30/20 Morgan Stanley
Morgan Stanley says buy Facebook amid boycott-driven weakness
06/30/20 Citi
Facebook shares overreacting to pause in ad spending, says Citi
FB Facebook
$239.06 /

+5.6 (+2.40%)

FB Facebook
$239.06 /

+5.6 (+2.40%)

FB Facebook
$239.06 /

+5.6 (+2.40%)

FB Facebook
$239.06 /

+5.6 (+2.40%)

Options
Dollar Tree call volume above normal and directionally bullish » 15:25
07/06/20
07/06
15:25
07/06/20
15:25
DLTR

Dollar Tree

$89.45 /

-4.13 (-4.41%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$89.45 /

-4.13 (-4.41%)

DLTR Dollar Tree
$89.45 /

-4.13 (-4.41%)

06/23/20 Loop Capital
Loop sees At Home, Dollar Tree as potential targets for activists
06/01/20 BMO Capital
Dollar Tree price target raised to $105 from $85 at BMO Capital
05/29/20 Guggenheim
Dollar Tree price target raised to $110 from $85 at Guggenheim
05/29/20 KeyBanc
Dollar Tree price target raised to $110 from $90 at KeyBanc
DLTR Dollar Tree
$89.45 /

-4.13 (-4.41%)

DLTR Dollar Tree
$89.45 /

-4.13 (-4.41%)

DLTR Dollar Tree
$89.45 /

-4.13 (-4.41%)

DLTR Dollar Tree
$89.45 /

-4.13 (-4.41%)

Technical Analysis
NASDAQ market internals summary » 15:17
07/06/20
07/06
15:17
07/06/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
07/06/20
07/06
15:16
07/06/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
FDA alerts clinical lab staff on COVID false positives risk with BD Max System » 15:11
07/06/20
07/06
15:11
07/06/20
15:11
BDX

Becton Dickinson

$250.30 /

+5.21 (+2.13%)

The U.S. Food and Drug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$250.30 /

+5.21 (+2.13%)

BDX Becton Dickinson
$250.30 /

+5.21 (+2.13%)

07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
BDX Becton Dickinson
$250.30 /

+5.21 (+2.13%)

  • 21
    May
BDX Becton Dickinson
$250.30 /

+5.21 (+2.13%)

Periodicals
Governor praises FL parks as low-risk COVID environments, Orlando Sentinel says » 15:09
07/06/20
07/06
15:09
07/06/20
15:09
DIS

Disney

$113.76 /

+1.53 (+1.36%)

, CMCSA

Comcast

$40.13 /

+0.88 (+2.24%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, SEAS

SeaWorld

$15.74 /

+0.465 (+3.04%)

Governor Ron DeSantis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$113.76 /

+1.53 (+1.36%)

CMCSA Comcast
$40.13 /

+0.88 (+2.24%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SEAS SeaWorld
$15.74 /

+0.465 (+3.04%)

DIS Disney
$113.76 /

+1.53 (+1.36%)

06/24/20 Morgan Stanley
Morgan Stanley says time might be right for Disney to move ESPN to streaming
06/19/20 Wells Fargo
Disney price target raised to $118 from $107 at Wells Fargo
06/15/20 BofA
BofA boosts Disney target to $146, sees 'compelling' entry point
06/09/20
Fly Intel: Top five analyst downgrades
CMCSA Comcast
$40.13 /

+0.88 (+2.24%)

07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Bernstein
Comcast upgraded to Outperform from Market Perform at Bernstein
06/26/20 Nomura Instinet
Comcast 'green shoots' are emerging, says Nomura Instinet
06/24/20 Benchmark
Sinclair Broadcast the 'obvious winner' in baseball's return, says Benchmark
CMCSK Comcast
$0.00 /

+ (+0.00%)

07/01/20
Fly Intel: Top five analyst upgrades
04/28/20 Wells Fargo
SeaWorld price target lowered to $16 from $36 at Wells Fargo
04/17/20 Oppenheimer
Comcast downgraded to Perform from Outperform at Oppenheimer
03/16/20
Fly Intel: Top five analyst downgrades
SEAS SeaWorld
$15.74 /

+0.465 (+3.04%)

06/09/20 B. Riley FBR
SeaWorld price target raised to $29 from $17 at B. Riley FBR
06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 Citi
Citi upgrades SeaWorld to Buy on 'compelling' risk/reward
06/04/20 Citi
SeaWorld upgraded to Buy from Neutral at Citi
DIS Disney
$113.76 /

+1.53 (+1.36%)

CMCSA Comcast
$40.13 /

+0.88 (+2.24%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SEAS SeaWorld
$15.74 /

+0.465 (+3.04%)

DIS Disney
$113.76 /

+1.53 (+1.36%)

CMCSA Comcast
$40.13 /

+0.88 (+2.24%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SEAS SeaWorld
$15.74 /

+0.465 (+3.04%)

DIS Disney
$113.76 /

+1.53 (+1.36%)

CMCSA Comcast
$40.13 /

+0.88 (+2.24%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SEAS SeaWorld
$15.74 /

+0.465 (+3.04%)

DIS Disney
$113.76 /

+1.53 (+1.36%)

CMCSA Comcast
$40.13 /

+0.88 (+2.24%)

SEAS SeaWorld
$15.74 /

+0.465 (+3.04%)

Options
Bloom Energy call volume above normal and directionally bullish » 15:05
07/06/20
07/06
15:05
07/06/20
15:05
BE

Bloom Energy

$11.79 /

+1.44 (+13.91%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BE Bloom Energy
$11.79 /

+1.44 (+13.91%)

BE Bloom Energy
$11.79 /

+1.44 (+13.91%)

05/28/20 JPMorgan
Bloom Energy price target raised to $17 from $14 at JPMorgan
05/12/20 Morgan Stanley
Bloom Energy's underlying demand still appears strong, says Morgan Stanley
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
03/09/20 JPMorgan
Solar stocks providing 'unanticipated safe haven,' says JPMorgan
BE Bloom Energy
$11.79 /

+1.44 (+13.91%)

BE Bloom Energy
$11.79 /

+1.44 (+13.91%)

BE Bloom Energy
$11.79 /

+1.44 (+13.91%)

BE Bloom Energy
$11.79 /

+1.44 (+13.91%)

Initiation
Insight Enterprises initiated with a Buy at Sidoti » 15:04
07/06/20
07/06
15:04
07/06/20
15:04
NSIT

Insight Enterprises

$48.09 /

+0.67 (+1.41%)

Sidoti initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSIT Insight Enterprises
$48.09 /

+0.67 (+1.41%)

NSIT Insight Enterprises
$48.09 /

+0.67 (+1.41%)

10/17/19 JPMorgan
JPMorgan 'incrementally constructive' on Insight's sales, margin trajectory
09/12/19 JPMorgan
Insight Enterprises initiated with an Overweight at JPMorgan
NSIT Insight Enterprises
$48.09 /

+0.67 (+1.41%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.